Medical

How to understand what’s next for Canadian cannabis

On August 18, along with Torkin Manes LLP, Business of Cannabis presented the online event, “Canadian Cannabis: What’s Next?”

On August 18, along with Torkin Manes LLP, Business of Cannabis presented the online event, “Canadian Cannabis: What’s Next?”

The event featured a series of segments where key industry leaders from throughout the cannabis supply chain provided their perspectives on what they believed was next in Canadian cannabis.

The event featured the following industry leaders:


Darren Karasiuk, CEO, NOVA Cannabis


Fern Glowinsky, CEO, Merrco Payments


David Kerr, Senior Vice President, Gallagher in Canada


Albert Kim, CEO, Greenline POS


Alison McMahon, CEO, Cannabis At Work


Tanner Stewart, CEO, Stewart Farms


Hardeep Stoker, Chief Product Officer, Elevated Signals


Lisa Campbell, CEO, Mercari Agency


Jenn Larry, CCO, MTL Cannabis


Ryan Lalonde, CEO, Buddi


George Scorsis, CEO, Entourage Health


Shahbaaz Kara-Virani, Canada Lead, Dutchie


Lucas McCann, Chief Scientific Officer, CannDelta


Lisa Bigioni, CEO, Stok’d Cannabis

Topicsbusiness of cannabiscannabiscannabis retaildispensaryhybrid eventmarijuanamedical cannabismedical marijuana

Spotted an error, or have a tip? Contact the newsroom.

Up next · Medical

DEA Issues First Federal Registrations to 900 Dispensaries, But Dual-Licence States Remain Uncertain

Ben Stevens · 2 November 2026

More